Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$22.03 USD
+0.24 (1.10%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $22.03 0.00 (0.00%) 6:24 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Surgery Partners, Inc. has a market cap of $2.79B, which represents its share price of $21.79 multiplied by its outstanding shares number of 128.21M. As a mid-cap company, SGRY's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SGRY 22.03 +0.24(1.10%)
Will SGRY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SGRY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGRY
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
Danaher (DHR) Q2 Earnings and Revenues Top Estimates
SGRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates
Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates
Other News for SGRY
Aveanna upgraded at J.P. Morgan on risk-reward setup
SGRY rises 1.07% on September 17, leaving the technical picture intact
SGRY: JP Morgan Initiates Coverage with 'Neutral' Rating | SGRY Stock News
Surgery Partners assumed with a Neutral at JPMorgan
Surgery Partners assumed with a Neutral at JPMorgan